PT1200106E - Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico - Google Patents

Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico

Info

Publication number
PT1200106E
PT1200106E PT00943697T PT00943697T PT1200106E PT 1200106 E PT1200106 E PT 1200106E PT 00943697 T PT00943697 T PT 00943697T PT 00943697 T PT00943697 T PT 00943697T PT 1200106 E PT1200106 E PT 1200106E
Authority
PT
Portugal
Prior art keywords
butyrospermum parkii
medication
extracts
composition containing
extract
Prior art date
Application number
PT00943697T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Bsp Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27512830&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1200106(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bsp Pharma As filed Critical Bsp Pharma As
Publication of PT1200106E publication Critical patent/PT1200106E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
PT00943697T 1999-07-09 2000-07-10 Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico PT1200106E (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA199901003 1999-07-09
DKPA199901323 1999-09-16
US15465199P 1999-09-20 1999-09-20
DKPA200000434 2000-03-16
US19091900P 2000-03-21 2000-03-21

Publications (1)

Publication Number Publication Date
PT1200106E true PT1200106E (pt) 2003-09-30

Family

ID=27512830

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00943697T PT1200106E (pt) 1999-07-09 2000-07-10 Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico

Country Status (14)

Country Link
US (3) US20050031709A1 (pt)
EP (2) EP1200106B2 (pt)
JP (1) JP2003504340A (pt)
CN (1) CN1367699A (pt)
AT (1) ATE239490T1 (pt)
AU (1) AU784718B2 (pt)
CA (1) CA2378396C (pt)
DE (1) DE60002581T2 (pt)
DK (1) DK1200106T3 (pt)
ES (1) ES2198324T3 (pt)
HK (1) HK1046502B (pt)
NZ (1) NZ517077A (pt)
PT (1) PT1200106E (pt)
WO (1) WO2001003712A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001007B1 (en) 1998-11-13 2008-04-09 Loders Croklaan B.V. Sterol concentrates, its application and preparation
JP2003002835A (ja) * 2001-06-21 2003-01-08 Unitika Ltd 機能性食品
NZ526969A (en) * 2001-01-12 2005-05-27 Bsp Pharma Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
JP4542300B2 (ja) * 2002-02-15 2010-09-08 株式会社ファンケル ヒアルロン酸蓄積促進剤
US7070815B2 (en) 2002-11-27 2006-07-04 Loders Croklaan Usa Llc Anti diarrhoea compositions
EP1424073A1 (en) * 2002-11-27 2004-06-02 Loders Croklaan B.V. Anti diarrhoea compositions
FR2859103B1 (fr) * 2003-09-02 2005-11-25 Silab Sa Procede d'obtention d'un principe actif detoxifiant pour la peau, principe actif obtenu
US20060003948A1 (en) * 2004-02-06 2006-01-05 Krasutsky Pavel A Compositions that include a triterpene and a carrier
DE102004030044A1 (de) 2004-06-22 2006-01-12 Birken Gmbh Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
FR2885527B1 (fr) * 2005-05-16 2007-06-29 Galderma Res & Dev Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
CH704033B1 (de) * 2007-03-26 2012-05-15 Swiss Caps Rechte Und Lizenzen Ag Kapseln enthaltend Pflanzenzubereitungen.
JP5428000B2 (ja) * 2007-06-27 2014-02-26 株式会社スカイライト・バイオテック ルペオール含有医薬組成物、食品及び飼料
WO2010104375A1 (en) 2009-03-12 2010-09-16 N.V. Nutricia Stigmasterol for the treatment of alzheimer's disease
FR2984748B1 (fr) * 2011-12-26 2017-02-10 Expanscience Lab Utilisation d'avocats mous entiers pour obtenir une huile d'avocat riche en insaponifiable
PL2784114T3 (pl) 2013-03-26 2016-04-29 Sa Minera Catalano Aragonesa Biodegradowalny polimer pochodzenia naturalnego
EP3443056B1 (en) * 2016-04-13 2022-08-10 AAK AB (Publ) Odourless shea based esters
IT201600093764A1 (it) * 2016-09-19 2018-03-19 Codex V Srl Insaponificabili di lipidi naturali per l’uso nel trattamento di patologie reumatiche
CN111356479A (zh) 2018-01-04 2020-06-30 安瑞特研究有限公司 含有白桦脂醇的桦树皮提取物及其制剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932662A (en) * 1960-04-13 1963-07-31 Laroche Navarron Lab Therapeutic compositions comprising butyrospermol
LU85130A1 (fr) * 1983-12-12 1985-09-12 Oreal Composition cosmetique aqueuse ou anhydre contenant une phase grasse a base d'huile de karite
US5262872A (en) * 1985-03-28 1993-11-16 Canon Kabushiki Kaisha Image forming apparatus with means for error detection
US5626872A (en) * 1992-06-16 1997-05-06 Roemmers S.A.I.C.F. Pharmaceutical soft capsules containing lysine clonixinate and a process for their preparation
FR2702773B1 (fr) † 1993-03-19 1995-06-16 Deslog Procede de preparation de fractions de matieres grasses d'origine vegetale enrichies en matieres insaponifiables.
DE4426148A1 (de) † 1994-07-22 1996-01-25 Henkel Kgaa Kosmetische und/oder pharmazeutische Zubereitungen
GB9515214D0 (en) * 1995-07-25 1995-09-20 Univ Strathclyde Plant extracts
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
DE69722210T2 (de) † 1996-07-05 2004-04-01 Unilever N.V. Verfahren zur herstellung einer mischung von sterin-estern
FR2770400B1 (fr) * 1997-10-30 1999-12-03 Sederma Sa Compositions a usage cosmetique ou dermopharmaceutique contenant un extrait vegetal obtenu a partir de la fleur de l'arbre a karite ou butyrospermum parkii kotschy
US6190170B1 (en) * 1998-05-05 2001-02-20 Dentech, Llc Automated tooth shade analysis and matching system
SE514725C2 (sv) † 1998-06-02 2001-04-09 Karlshamns Ab Fraktioneringsförfarande

Also Published As

Publication number Publication date
DE60002581D1 (de) 2003-06-12
CA2378396A1 (en) 2001-01-18
CA2378396C (en) 2010-12-21
US20050031709A1 (en) 2005-02-10
ES2198324T3 (es) 2004-02-01
NZ517077A (en) 2003-11-28
EP1200106B2 (en) 2010-08-11
AU784718B2 (en) 2006-06-01
DE60002581T2 (de) 2004-03-25
DK1200106T3 (da) 2003-10-27
EP1200106B1 (en) 2003-05-07
US20080124413A1 (en) 2008-05-29
HK1046502B (zh) 2003-09-19
CN1367699A (zh) 2002-09-04
HK1046502A1 (en) 2003-01-17
EP1200106A1 (en) 2002-05-02
ATE239490T1 (de) 2003-05-15
WO2001003712A1 (en) 2001-01-18
EP1354595A1 (en) 2003-10-22
AU5806600A (en) 2001-01-30
JP2003504340A (ja) 2003-02-04
US20070003645A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
PT1200106E (pt) Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico
US20020110604A1 (en) Composition exhibiting synergistic antioxidant activity
WO2006014673A3 (en) Insulin-oligomer conjugates, formulations and uses thereof
EP2246049A3 (en) Pharmaceutical composition and dosage forms for administration of hydrophobic drugs
AU2002231544A1 (en) Therapeutic uses of herbal compositions
DK1156814T3 (da) Farmaceutika, kosttilskud og kosmetiske præparater omfattende en fedtsyre og ingefær
EP1834637A4 (en) COMPOSITION FOR THE PREVENTION / TREATMENT OF DISEASES THROUGH FREE RADICALS
WO2007064968A3 (en) Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate
CA2514224A1 (en) Liquid pharmaceutical formulations of palonosetron
EP2263667A3 (en) Compositions comprising crystalline trans-(+/-)-delta-9-tetrahydrocannabinol
AU2874099A (en) Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
MY143549A (en) Compositions for external application, containing adenosyl cobalamin for improvement of skin diseases
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
MXPA06000243A (es) Formulacion farmaceutica liofilizada estable de tetrodotoxina.
CA2556520A1 (en) Chromium-fatty acid compounds and methods of making and using thereof
HUP0304077A2 (hu) A bőr öregedése elleni gyógyászati és kozmetikai készítmények
IL146284A0 (en) Androgen glycosides and pharmaceutical compositions containing the same
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
WO2001074780A8 (en) Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
WO2002072035A3 (en) Novel anti-inflammatory compositions and methods of use
WO2003002117A3 (en) Niaciamide and derivatives in combination with aminosugar
WO2003043632A3 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AR035988A1 (es) Derivados de pirrolo-(3,4-b)quinoleina, su procedimiento de preparacion y su uso para la preparacion de medicamento
CA2439685A1 (en) Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations
AU7411194A (en) Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles